A comprehensive clinical review identifies emerging neurologic complications across substance classes, with particular attention to potential cannabis-stroke associations. The review provides neurologists with systematic approaches for recognizing substance-related neurologic syndromes and highlights the need for updated clinical vigilance as drug supplies and legalization patterns evolve.